BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36428474)

  • 1. Macrophage-Targeted Sodium Chlorite (NP001) Slows Progression of Amyotrophic Lateral Sclerosis (ALS) through Regulation of Microbial Translocation.
    Zhang R; Bracci PM; Azhir A; Forrest BD; McGrath MS
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analyses.
    Miller RG; Zhang R; Bracci PM; Azhir A; Barohn R; Bedlack R; Benatar M; Berry JD; Cudkowicz M; Kasarskis EJ; Mitsumoto H; Manousakis G; Walk D; Oskarsson B; Shefner J; McGrath MS
    Muscle Nerve; 2022 Jul; 66(1):39-49. PubMed ID: 35098554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis.
    Lunetta C; Lizio A; Maestri E; Sansone VA; Mora G; Miller RG; Appel SH; Chiò A
    JAMA Neurol; 2017 Jun; 74(6):660-667. PubMed ID: 28384752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
    Miller RG; Block G; Katz JS; Barohn RJ; Gopalakrishnan V; Cudkowicz M; Zhang JR; McGrath MS; Ludington E; Appel SH; Azhir A;
    Neurol Neuroimmunol Neuroinflamm; 2015 Jun; 2(3):e100. PubMed ID: 25884010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.
    Miller RG; Zhang R; Block G; Katz J; Barohn R; Kasarskis E; Forshew D; Gopalakrishnan V; McGrath MS
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):601-9. PubMed ID: 25192333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.
    McGrath MS; Zhang R; Bracci PM; Azhir A; Forrest BD
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.
    Kharel S; Ojha R; Preethish-Kumar V; Bhagat R
    Brain Behav; 2022 Mar; 12(3):e2532. PubMed ID: 35201675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
    Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis.
    Cao MC; Cawston EE; Chen G; Brooks C; Douwes J; McLean D; Graham ES; Dragunow M; Scotter EL
    BMC Neurol; 2022 Jun; 22(1):216. PubMed ID: 35690735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis.
    Yang B; Wu Y; Wang Y; Yang H; Du B; Di W; Xu X; Shi X
    Neurol Sci; 2020 Oct; 41(10):2915-2920. PubMed ID: 32338335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Chitotriosidase and CC-Chemokine Ligand 18 as Biomarkers of Microglia Activation in Amyotrophic Lateral Sclerosis.
    Martinez-Merino L; Iridoy M; Galbete A; Roldán M; Rivero A; Acha B; Irún P; Canosa C; Pocoví M; Mendioroz M; Jericó I
    Neurodegener Dis; 2018; 18(4):208-215. PubMed ID: 30134252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis.
    Thompson AG; Gray E; Thézénas ML; Charles PD; Evetts S; Hu MT; Talbot K; Fischer R; Kessler BM; Turner MR
    Ann Neurol; 2018 Feb; 83(2):258-268. PubMed ID: 29331073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Citrulline Level and Transporter Activity Are Altered in Experimental Models of Amyotrophic Lateral Sclerosis.
    Gyawali A; Gautam S; Hyeon SJ; Ryu H; Kang YS
    Mol Neurobiol; 2021 Feb; 58(2):647-657. PubMed ID: 33000451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of clinical and inflammatory markers in patients with amyotrophic lateral sclerosis.
    Prado LGR; Rocha NP; de Souza LC; Bicalho ICS; Gomez RS; Vidigal-Lopes M; Braz NFT; Vieira ÉLM; Teixeira AL
    J Neurol Sci; 2018 Nov; 394():69-74. PubMed ID: 30219498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
    Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
    Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis.
    Nomura M; Oketa Y; Yasui K; Ishikawa H; Ono S
    Acta Neurol Scand; 2012 Jun; 125(6):389-97. PubMed ID: 21824113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis.
    Zubiri I; Lombardi V; Bremang M; Mitra V; Nardo G; Adiutori R; Lu CH; Leoni E; Yip P; Yildiz O; Ward M; Greensmith L; Bendotti C; Pike I; Malaspina A
    Mol Neurodegener; 2018 Nov; 13(1):60. PubMed ID: 30404656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.
    Imamura K; Izumi Y; Banno H; Uozumi R; Morita S; Egawa N; Ayaki T; Nagai M; Nishiyama K; Watanabe Y; Hanajima R; Oki R; Fujita K; Takahashi N; Ikeda T; Shimizu A; Morinaga A; Hirohashi T; Fujii Y; Takahashi R; Inoue H
    BMJ Open; 2019 Dec; 9(12):e033131. PubMed ID: 31796494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis.
    Lunetta C; Lizio A; Gerardi F; Tarlarini C; Filippi M; Riva N; Tremolizzo L; Diamanti S; Dellanoce CC; Mosca L; Sansone VA; Campolo J
    J Neurol; 2020 Dec; 267(12):3609-3616. PubMed ID: 32638112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.